Skip to main content
. 2017 Dec 23;9(9):8290–8302. doi: 10.18632/oncotarget.23662

Table 1. Correlations of PRDX1 expression with clinicopathological variables of osteosarcoma in training and validation cohort.

Variables Training Cohort Validation Cohort
PRDX1 Expression PRDX1 Expression
N Low High P value No. Low High P value
Gender
 Male 75 31 44 0.676 67 22 45 0.584
 Female 35 13 22 23 9 14
Age (years)
 < 45 57 20 37 0.275 54 19 35 0.856
 > 45 53 24 29 36 12 24
Anatomical site
 Femur/Tibia 89 36 53 0.843 67 21 46 0.291
 Elsewhere 21 8 13 23 10 13
Tumor size (cm)
 < 8 50 30 20 < 0.001 41 22 19 < 0.001
 > 8 60 14 46 49 9 40
ALP level(U/L)
 < 150 44 16 28 0.525 31 11 20 0.880
 > 150 66 28 38 59 20 39
Pathological fracture
 Absent 91 41 50 0.018 69 27 17 < 0.001
 Present 19 3 16 21 4 42
Ennecking grade
 2a 61 30 31 0.028 47 23 24 0.002
 2b 49 14 35 43 8 35
Histologic grade
 Low 65 33 32 0.006 47 24 23 0.001
 High 45 11 34 44 8 36
TNM stage
 I/II 62 32 30 0.005 47 25 22 < 0.001
 III 48 12 36 43 6 37